Pinterest
NewsLetter DailyWeekly
 
My HanCinema | Sign up, Why ? Your E-mail   Password    Auto| Help
HanCinema :: The Korean Movie and Drama Database, discover the South Korean cinema and drama diversity Contact HanCinema HanCinema on TwitterFaceBook HanCinema PageHanCinema on Twitter

[HanCinema's News] "Dr. Romantic 2" Criticized for Implausibility

2020/01/17

Though "Dr. Romantic 2" has been enjoying powerfully strong ratings, criticism of the drama's writing relative to the first season has been seeping in. In the most recent episode a young doctor played by Lee Sung-kyung takes a pill to calm herself prior to her first surgery. She subsequently collapses in an apparent overdose.

Online fans were highly critical of these events, expressing criticism that a doctor could be so ignorant as to make such a mistake. Criticism was also directed toward Lee Sung-kyung's perceived lack of acting talent in the situation, echoing previous complaints about the deemphasis of the original cast for newer characters. Plausibility was another major factor, as "Dr. Romantic" was famed for its realism.

However, other fans expressed faith in the drama's ability to follow through. Additionally, persons claiming to be doctors have chimed in on the subject to suggest that such errors are quite common in the medical profession, particularly younger ones, but underreported to avoid making normal persons lose too much faith in medical professionals. "Dr. Romantic 2" airs on Mondays and Tuesdays on SBS.

Written by William Schwartz

___________

"Dr. Romantic 2" is directed by Lee Gil-bok, Yoo In-sik, written by Kang Eun-kyeong, and features Han Suk-kyu, Ahn Hyo-seop, Lee Sung-kyung, Kim Joo-hun, Shin Dong-wook, So Joo-yeon. Broadcasting information in Korea: 2020/01/06~Now airing, Mon, Tue 22:00 on SBS.

Copy & paste guideline for this article
Always put a link back to the source and HanCinema permalink

Creative Commons License"[HanCinema's News] "Dr. Romantic 2" Criticized for Implausibility"
by HanCinema is licensed under a Creative Commons Attribution-Share Alike 3.0 Unported License.

Attention You're reading the news with potential spoilers, make them spoiler free, dismiss


 

 

 Previous news